Owner University of Maryland, Baltimore

Inventors Nataro, James

Agent Davies Collison Cave

Pub. Number AU-B-2002368026

PCT Number PCT/US02/38235

PCT Pub. Number WO2004/009759

Priority 60/398,775 26.07.02 US; 60/334,425 30.11.01 US

Filing date 2 December 2002

Wipo publication date 9 February 2004

Acceptance publication date 6 December 2007

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/108 (2006.01) Medicinal preparations containing antigens or antibodies - Escherichia

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C07K 14/245 (2006.01) Peptides having more than 20 amino acids

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

G01N 33/536 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with immune complex formed in liquid phase

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

A61K 38/00 (2006.01) Medicinal preparations containing peptides